251 related articles for article (PubMed ID: 10893240)
21. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
22. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
[TBL] [Abstract][Full Text] [Related]
23. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.
Li CG; Cui WY; Wang H
Acta Pharmacol Sin; 2016 Jan; 37(1):134-42. PubMed ID: 26725741
[TBL] [Abstract][Full Text] [Related]
25. Comparative aspects of the function and mechanism of SUR1 and MDR1 proteins.
Ueda K; Matsuo M; Tanabe K; Morita K; Kioka N; Amachi T
Biochim Biophys Acta; 1999 Dec; 1461(2):305-13. PubMed ID: 10581363
[TBL] [Abstract][Full Text] [Related]
26. Regulation of KATP channel expression and activity by the SUR1 nucleotide binding fold 1.
Masia R; Caputa G; Nichols CG
Channels (Austin); 2007; 1(4):315-23. PubMed ID: 18708750
[TBL] [Abstract][Full Text] [Related]
27. The ATPase activities of sulfonylurea receptor 2A and sulfonylurea receptor 2B are influenced by the C-terminal 42 amino acids.
de Wet H; Fotinou C; Amad N; Dreger M; Ashcroft FM
FEBS J; 2010 Jun; 277(12):2654-62. PubMed ID: 20553499
[TBL] [Abstract][Full Text] [Related]
28. Assembly limits the pharmacological complexity of ATP-sensitive potassium channels.
Giblin JP; Cui Y; Clapp LH; Tinker A
J Biol Chem; 2002 Apr; 277(16):13717-23. PubMed ID: 11825905
[TBL] [Abstract][Full Text] [Related]
29. Localization of the sulphonylurea receptor subunits, SUR2A and SUR2B, in rat renal tubular epithelium.
Zhou M; He HJ; Tanaka O; Suzuki R; Sekiguchi M; Yasuoka Y; Kawahara K; Itoh H; Abe H
Tohoku J Exp Med; 2008 Mar; 214(3):247-56. PubMed ID: 18323694
[TBL] [Abstract][Full Text] [Related]
30. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel.
Shindo T; Katayama Y; Horio Y; Kurachi Y
J Pharmacol Exp Ther; 2000 Jan; 292(1):131-5. PubMed ID: 10604939
[TBL] [Abstract][Full Text] [Related]
31. NEM modification prevents high-affinity ATP binding to the first nucleotide binding fold of the sulphonylurea receptor, SUR1.
Matsuo M; Tucker SJ; Ashcroft FM; Amachi T; Ueda K
FEBS Lett; 1999 Sep; 458(3):292-4. PubMed ID: 10570926
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the trafficking efficiency and functional properties of ATP-sensitive potassium channels through a single amino acid in the sulfonylurea receptor.
Cartier EA; Shen S; Shyng SL
J Biol Chem; 2003 Feb; 278(9):7081-90. PubMed ID: 12496311
[TBL] [Abstract][Full Text] [Related]
33. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
[TBL] [Abstract][Full Text] [Related]
35. Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels.
Wheeler A; Wang C; Yang K; Fang K; Davis K; Styer AM; Mirshahi U; Moreau C; Revilloud J; Vivaudou M; Liu S; Mirshahi T; Chan KW
Mol Pharmacol; 2008 Nov; 74(5):1333-44. PubMed ID: 18723823
[TBL] [Abstract][Full Text] [Related]
36. Syntaxin-1A interacts with distinct domains within nucleotide-binding folds of sulfonylurea receptor 1 to inhibit beta-cell ATP-sensitive potassium channels.
Chang N; Liang T; Lin X; Kang Y; Xie H; Feng ZP; Gaisano HY
J Biol Chem; 2011 Jul; 286(26):23308-18. PubMed ID: 21540180
[TBL] [Abstract][Full Text] [Related]
37. Identification of the potassium channel opener site on sulfonylurea receptors.
Uhde I; Toman A; Gross I; Schwanstecher C; Schwanstecher M
J Biol Chem; 1999 Oct; 274(40):28079-82. PubMed ID: 10497157
[TBL] [Abstract][Full Text] [Related]
38. Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K
Vedovato N; Rorsman O; Hennis K; Ashcroft FM; Proks P
J Physiol; 2018 Dec; 596(24):6205-6217. PubMed ID: 30179258
[TBL] [Abstract][Full Text] [Related]
39. Cloning of rabbit Kir6.1, SUR2A, and SUR2B: possible candidates for a renal K(ATP) channel.
Brochiero E; Wallendorf B; Gagnon D; Laprade R; Lapointe JY
Am J Physiol Renal Physiol; 2002 Feb; 282(2):F289-300. PubMed ID: 11788443
[TBL] [Abstract][Full Text] [Related]
40. NMR and fluorescence studies of drug binding to the first nucleotide binding domain of SUR2A.
López-Alonso JP; de Araujo ED; Kanelis V
Biochemistry; 2012 Nov; 51(45):9211-22. PubMed ID: 23078514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
